Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology.

Autor: Rogers JP; Division of Psychiatry, University College London, London, UK.; South London and Maudsley NHS Foundation Trust, London, UK., Oldham MA; Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA., Fricchione G; Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Northoff G; Mind, Brain Imaging and Neuroethics Research Unit, The Royal's Institute of Mental Health Research, University of Ottawa, Ottawa, ON, Canada., Ellen Wilson J; Veterans Affairs, Geriatric Research, Education and Clinical Center, Tennessee Valley Healthcare System, Nashville, TN, USA.; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA., Mann SC; Private Practice, Harleysville, PA, USA., Francis A; Penn State Medical School, Hershey Medical Center, PA, USA., Wieck A; Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.; Institute of Population Health, University of Manchester, Manchester, UK., Elizabeth Wachtel L; Kennedy Krieger Institute, Baltimore, Maryland, USA.; Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Lewis G; Division of Psychiatry, University College London, London, UK., Grover S; Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, CH, India., Hirjak D; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Ahuja N; Regional Affective Disorders Service, Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle, UK., Zandi MS; Queen Square Institute of Neurology, University College London, London, UK.; National Hospital for Neurology and Neurosurgery, London, UK., Young AH; South London and Maudsley NHS Foundation Trust, London, UK.; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK., Fone K; School of Life Sciences, Queen's Medical Centre, The University of Nottingham, Nottingham, UK., Andrews S; Patient and Retired Physician, Liverpool, UK., Kessler D; Centre for Academic Mental Health, University of Bristol, Bristol, UK., Saifee T; National Hospital for Neurology and Neurosurgery, London, UK., Gee S; Pharmacy Department, South London and Maudsley NHS Foundation Trust, London, UK.; Faculty of Life Sciences and Medicine, King's College London, London, UK., Baldwin DS; Clinical Neuroscience, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., David AS; Institute of Mental Health, University College London, London, UK.
Jazyk: angličtina
Zdroj: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2023 Apr; Vol. 37 (4), pp. 327-369. Date of Electronic Publication: 2023 Apr 11.
DOI: 10.1177/02698811231158232
Abstrakt: The British Association for Psychopharmacology developed an evidence-based consensus guideline on the management of catatonia. A group of international experts from a wide range of disciplines was assembled. Evidence was gathered from existing systematic reviews and the primary literature. Recommendations were made on the basis of this evidence and were graded in terms of their strength. The guideline initially covers the diagnosis, aetiology, clinical features and descriptive epidemiology of catatonia. Clinical assessments, including history, physical examination and investigations are then considered. Treatment with benzodiazepines, electroconvulsive therapy and other pharmacological and neuromodulatory therapies is covered. Special regard is given to periodic catatonia, malignant catatonia, neuroleptic malignant syndrome and antipsychotic-induced catatonia. There is attention to the needs of particular groups, namely children and adolescents, older adults, women in the perinatal period, people with autism spectrum disorder and those with certain medical conditions. Clinical trials were uncommon, and the recommendations in this guideline are mainly informed by small observational studies, case series and case reports, which highlights the need for randomised controlled trials and prospective cohort studies in this area.
Databáze: MEDLINE